We are #hiring a (Senior) Research Associate to join our Immunology team in New York City. Apply now or share this post with your network!
Aethon Therapeutics’ Post
More Relevant Posts
-
CEO, Rajesh Chopra, and Exec. Dir of Proteomics, Lauren Stopfer, are attending the NewYorkBIO Innovation Summit 2024 today as panelists in the session titled, "Growth opportunities and challenges for life science companies in New York." Should be a great discussion! https://lnkd.in/e5KsYirr
To view or add a comment, sign in
-
It has come to our attention scammers are impersonating our company for false employment opportunities. Stay vigilant, job seekers! Here is a helpful resource on what to look out for: https://lnkd.in/dgkrq6cz
Scammers impersonate well-known companies, recruit for fake jobs on LinkedIn and other job platforms
consumer.ftc.gov
To view or add a comment, sign in
-
NEW PUBLICATION! HapImmune Platform co-inventor (and now Aethon Therapeutics employee), Lorenzo Maso and team, describes the "molecular basis for antibody recognition of multiple drug-peptide/MHC complexes" in this new PNAS publication: https://lnkd.in/e_qRxBGD This manuscript is full of structure-based insights relevant to haptenated pMHCs, bispecific T-cell engagers, and antibody engineering. Congrats to the team from New York University on this impressive new publication.
Molecular basis for antibody recognition of multiple drug–peptide/MHC complexes | Proceedings of the National Academy of Sciences
pnas.org
To view or add a comment, sign in
-
Aethon’s unique platform and approach is featured in the latest Genetic Engineering & Biotechnology News – check it out! Multispecific Antibodies Come to Grips with Manifold Targets (genengnews.com) https://lnkd.in/eeZ3N252
Multispecific Antibodies Come to Grips with Manifold Targets
genengnews.com
To view or add a comment, sign in
-
What a past week for Aethon—an earthquake on April 5th and a solar eclipse on April 8th! We love capturing the little and big moments at Aethon Therapeutics on our Polaroid camera 📸
To view or add a comment, sign in
-
We are excited to announce our collaboration with Revolution Medicines to create novel bispecific antibodies directed towards cancer neoantigens generated by Revolution Medicines’ RAS(ON) inhibitors. https://lnkd.in/eSRG3YYs
Aethon Therapeutics Announces Collaboration with Revolution Medicines to Discover and Develop Novel Aethon Antibody Programs
prnewswire.com
To view or add a comment, sign in
-
We’re #hiring! Aethon is looking to hire a skilled candidate in the field of protein engineering to support our antibody discovery and engineering efforts. This is a great opportunity to work in a fast paced, dynamic, startup environment in New York City! Please apply or share to your network! #startup #biotech #antibodydiscovery
To view or add a comment, sign in
-
We are #hiring an Office Manager at Aethon Therapeutics to join our growing team in New York City for 2024. We are looking for an organized and adaptable individual, ideally with a background in biology or with previous administrative/management experience in a biotechnology environment. Apply now or share this post with your network!
To view or add a comment, sign in
-
Aethon Therapeutics reposted this
In my “view,” Aethon Therapeutics had a great first year! We had a wonderful time celebrating our 2023 accomplishments as a new #startup, which included building & opening our lab in New York City, and hiring a fantastic team of 9 talented scientists and engineers, working hard to push Aethon’s science forward. As the “first” employee of Aethon, I am so proud of where we are, and even more excited about where we’re going 😊
To view or add a comment, sign in
1,804 followers